Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(20)32463-3
Abstract: Novel diabetes agents (glucagon-like-peptide-1 receptor agonists, GLP-1 RA and sodium-glucose cotransport-2 inhibitors, SGLT2i) reduced death and cardiovascular events in randomized trials, but uptake in clinical practice has lagged. We assessed the unrealized potential for reduction…
read more here.
Keywords:
potential unrealized;
diabetes agents;
unrealized cardiovascular;
novel diabetes ... See more keywords